Johnson & Johnson (NYSE:JNJ) has announced the resignation of Sheri S. McCoy, Vice Chairman of the Executive Committee.

Johnson & Johnson Loses Exec Committee Vice Chair

The US based Johnson & Johnson has said that Sheri S. McCoy, Vice Chairman of the Executive Committee, has resigned from the Company effective April 18 to join another publicly traded company as CEO.

William C. Weldon, Chairman and CEO of Johnson & Johnson (NYSE:JNJ) said, “Sheri has made important contributions across Johnson & Johnson (NYSE:JNJ) throughout her career. During these last several years, she was instrumental in helping to bring stronger strategic focus to our Pharmaceutical business as it builds a robust pipeline and launches important new medicines; and to our Consumer business as it leverages the success of its iconic brands and worked to resolve some recent challenges.”

Johnson & Johnson (NYSE:JNJ) shares were at 64.20 at the end of the last day’s trading. There’s been a 0.0% change in the stock price over the past 3 months.

Johnson & Johnson (NYSE:JNJ) Analyst Advice
Consensus Opinion: Moderate Buy
Mean recommendation: 2
(1=Strong Buy, 5=Strong Sell)
3 Months Ago: 1.91
Zack’s Rank: 5 out of 14 in the industry